New authorised medicine: ESPEROCT (turoctocog alfa pegol)

28 juin 2019

BlueRegWatch

ESPEROCT is a medicine used to treat and prevent bleeding in patients with haemophilia A, an inherited bleeding disorder caused by the lack of a clotting protein known as factor VIII. ESPEROCT can be used in adults and children from 12 years of age.

BlueRegWatch

Vous avez aimé cet article ? Partagez le sur les réseaux sociaux :

Découvrez notre dernier livre blanc

En savoir plus